Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank95
5Y CAGR+7.9%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+7.9%/yr
Long-term compound
Percentile
P95
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 33.11% |
| Q2 2025 | -26.99% |
| Q1 2025 | -23.30% |
| Q4 2024 | -25.03% |
| Q3 2024 | -26.95% |
| Q2 2024 | -23.00% |
| Q1 2024 | -14.40% |
| Q4 2023 | -14.21% |
| Q3 2023 | -12.28% |
| Q2 2023 | -19.07% |
| Q1 2023 | -12.38% |
| Q4 2022 | -9.89% |
| Q3 2022 | -11.33% |
| Q2 2022 | -32.87% |
| Q1 2022 | -15.24% |
| Q4 2021 | 7.16% |
| Q3 2021 | -14.61% |
| Q2 2021 | 33.21% |
| Q1 2021 | -19.91% |
| Q4 2020 | 4.64% |
| Q3 2020 | 22.67% |
| Q2 2020 | -26.77% |
| Q1 2020 | 57.27% |
| Q4 2019 | -72.42% |
| Q3 2019 | -2.31% |
| Q2 2019 | -5.88% |
| Q1 2019 | 8.98% |
| Q4 2018 | -39.75% |
| Q3 2018 | -8.81% |
| Q2 2018 | -4.83% |
| Q1 2018 | -1.20% |
| Q4 2017 | 4.90% |
| Q3 2017 | -2.46% |
| Q2 2017 | 0.56% |
| Q1 2017 | -2.28% |
| Q4 2016 | -39.59% |
| Q3 2016 | 0.13% |
| Q2 2016 | -2.62% |
| Q1 2016 | 0.79% |
| Q4 2015 | -14.83% |